ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

October 22, 2010

Cancer Letter Office Moves To Capitol Hill; No Issues Published Next Two Weeks

September 1, 1989

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

Trials Approved by NCI CTEP For the Month of March

March 30, 2012

Should Be Cut First, DCT Board Says

December 4, 1981

Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding

September 18, 1992